Topiramate
Product Images NDC 12634-452

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 12634-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (452 71)

Topiramate 25 mg tablets packaging label from APOTHECA, INC. The label indicates a bottle containing 30 tablets with NDC 12634-452-71. It specifies the product as prescription only and mentions comparison to Topamax. The label includes usage instructions to take tablets by mouth as directed by a physician, storage conditions, and safety warnings regarding keeping medication out of children's reach and consulting a doctor before use.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of topiramate showing its molecular configuration with multiple oxygen atoms, methyl groups, and a sulfonamide moiety.*

FDA Label Image

Figure-1 (Figure 1)

Kaplan-Meier estimates of cumulative rates over time to first seizure are shown for Topiramate at doses of 50 mg/day and 400 mg/day. The graph plots cumulative rates for time to first seizure on the vertical axis against time in days on the horizontal axis, comparing the two dosage groups with sample sizes of 234 and 236 respectively.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.